SWA
OSTX

Stratos Wealth Advisors’s OS Therapies Inc OSTX Stock Holding History

Stratos Wealth Advisors’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.7K Buy
19,314
+5,497
+40% +$9.22K ﹤0.01% 637
2026
Q1 		$19.5K Hold
13,817
– – ﹤0.01% 608
2025
Q4 		$19.3K Buy
+13,817
New +$24.9K ﹤0.01% 653

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stratos Wealth Advisors's OSTX Position: Q2 2026 in Review

Stratos Wealth Advisors increased its OS Therapies Inc (OSTX) stake by 40% in Q2 2026, buying an estimated $9.22K and bringing the position to 19,314 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Stratos Wealth Advisors first reported a position in OSTX in Q4 2025 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Stratos Wealth Advisors held 19,314 shares of OS Therapies Inc worth $36.7K as of Q2 2026.
  • Stratos Wealth Advisors bought 5,497 OS Therapies Inc shares in Q2 2026, an estimated $9.22K.
  • OS Therapies Inc made up ﹤0.01% of Stratos Wealth Advisors's portfolio in Q2 2026, its #637 holding.
  • Stratos Wealth Advisors first reported a position in OS Therapies Inc in Q4 2025 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.